All news

Pic:getty/manjurul

GSK gets FDA approval for MMR vaccine Priorix

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved GSK’s Priorix (Measles, Mumps and Rubella Vaccine, Live) for individuals 12 months of age and older.

Pic:getty/cristianstortografia

Monkeypox: The vaccine landscape

By Rachel Arthur

Interest in vaccines against monkeypox is growing as the outbreak spreads around the world. The arsenal includes existing smallpox vaccines and potential new monkeypox specific mRNA vaccines.

Pic:getty/tetianagarkusha

mRNA tech ‘reason for hope’ on path to HIV vaccine

By Ben Hargreaves

With mRNA tech achieving major success against COVID-19, the initiation of trials into vaccination against HIV is creating discussion amid a potential breakthrough in the prevention of the disease.

Pic:getty/diegograndi

How Lithuania aims to become a leading European biotech hub

By Ben Hargreaves

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

Pic:getty/andrewbrookes

GSK acquires vaccine company Affinivax

By Rachel Arthur

GSK will acquire Affinivax, a US clinical-stage biopharmaceutical company, for a $2.1bn upfront payment and up to $1.2bn in potential development milestones.

Pic:getty/omersukrugoksu

Lilly invests $2.1bn in new Indiana manufacturing sites

By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Northway Biotech US facility delegation tour © Armonaite Vladas

Lithuanian CDMO to open facility in Boston

By Jane Byrne

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.

Pic:getty/ERproductionslimited

NIH awards $577m to antiviral drug developers

By Rachel Arthur

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Pic: getty/geritK

WHO validates 11th COVID-19 vaccine

By Rachel Arthur

The World Health Organization (WHO) has today issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by CanSino Biologics, bringing the total number of COVID-19 vaccines validated by the organisation to 11.